Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.43 - $70.83 $767,983 - $1.28 Million
-18,100 Reduced 60.33%
11,900 $810,000
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $13.4 Million - $24.1 Million
-325,000 Reduced 91.55%
30,000 $1.27 Million
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $11.3 Million - $14.8 Million
200,000 Added 129.03%
355,000 $24.5 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $7.68 Million - $9.84 Million
130,000 Added 520.0%
155,000 $11.5 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $582,924 - $883,965
9,300 Added 59.24%
25,000 $2.35 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $740,883 - $1.11 Million
15,700 New
15,700 $1.07 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.